Oncopeptides AB (ONCO)
Market Closed
12 Dec, 15:25
XSTO 
kr
5. 17
-0.17
-3.18%
kr
- Market Cap
- P/E Ratio
0% Div Yield
1,225,503 Volume
0 Eps
kr 5.34
Previous Close Day Range
5.16 5.35
Year Range
1.1 6.96
Want to track ONCO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 68 days
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| OND OND Oncopeptides AB 19 Feb 2026 (In 2 months) | | - | - |
| OND OND Oncopeptides AB 5 Nov 2025 | | - | - |
| OND OND Oncopeptides AB 21 Aug 2025 | | - | - |
| OND OND Oncopeptides AB 8 May 2025 | | - | - |
| OND OND Oncopeptides AB 25 Feb 2025 | | - | - |
| OND OND Oncopeptides AB 7 Nov 2024 | | - | - |
| OND OND Oncopeptides AB 14 Aug 2024 | | - | - |
| OND OND Oncopeptides AB 31 May 2024 | | - | - |
ONCO Earnings Reports FAQ
What is the earnings per share (EPS) for ONCO?
The current EPS is 0.
What is the company's earnings growth rate?
Oncopeptides AB has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-02-19, based on the ONCO's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Oncopeptides AB are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for ONCO at this time, as Oncopeptides AB has no recent EPS data to calculate it.
2025 © Marketlog. All Rights Reserved.
